Answers are grounded in this paper and cite their sources.
Anemia in pregnancy is a prevalent condition that can lead to severe complications for both mothers and their fetuses. Differentiating between the causes of anemia, particularly iron deficiency anemia (IDA) and thalassemia traits, is crucial for appropriate treatment. The Mentzer Index (MI) is a simple, cost-effective tool used to distinguish between these two common causes of microcytic anemia by comparing the mean corpuscular volume (MCV) to the red blood cell (RBC) count. This review explores the clinical utility of the MI in pregnancy anemia screening programs, highlighting its advantages, limitations, and potential role in improving diagnosis and management. The Mentzer Index has proven to be an effective first-line diagnostic tool, especially in resource-limited settings where advanced testing may not be readily available. By providing a straightforward method to differentiate IDA from thalassemia traits, the MI helps prevent the inappropriate use of iron supplements, which can exacerbate complications in individuals with thalassemia. Additionally, its simplicity allows for its incorporation into routine prenatal care, improving the efficiency of anemia screening programs and facilitating early intervention. Despite its benefits, the MI has limitations, including its reduced accuracy in pregnancy due to physiological changes and mixed anemia.
No takes yet. Share an insight, caveat, or question.
Emmanuel Ifeanyi Obeagu (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: